Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 03 December 2020 11:51 am  |  Updated:  Thursday 03 December 2020 11:52 am

Dr Fauci joins EU leaders in slamming Britain for swift vaccine approval

By: Poppy Wood

Add as a preferred source on Google
Members Of Coronavirus Task Force Hold A Briefing At The White House

American chief medical adviser has joined the EU in slamming Britain’s swift approval of the Pfizer/Biontech coronavirus vaccine.

“If you go quickly and you do it superficially, people are not going to want to get vaccinated,” America’s top immunologist Dr. Anthony Fauci told Fox News. “We have the gold standard of a regulatory approach with the FDA [Food and Drug Administration].

“The UK did not do it as carefully,” he added. “They got a couple of days ahead. I don’t think that makes much difference.”

It comes after the UK yesterday became the first country in the world to approve a coronavirus vaccine.

British health officials gave the green light for Pfizer and Biontech’s Covid vaccine to be rolled out to the public, after receiving a recommendation for use by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Vaccines usually take around a decade from start to finish to hit the shelves, whereas the Pfizer vaccine will be rolled out just under 10 months after it was first developed.

The government has ordered 40m doses of the vaccine, with the first 800,000 — enough to vaccinate 400,000 people — set to be distributed to hospital hubs across the UK over the next few days.

Speaking at last night’s Downing Street press conference, Prime Minister Boris Johnson hailed the “biological jiu jitsu” of the vaccine, telling the public it meant the pandemic would be over by the spring.

But the EU was swift to criticise the move yesterday, saying its own procedure was more thorough. 

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

In a terse statement yesterday the European Medicines Agency (EMA), which is in charge of approving Covid-19 vaccines for the EU, said its longer approval procedure required more checks than the emergency procedure chosen by Britain.

A spokesman for the European Commission said the EMA’s procedure was “the most effective regulatory mechanism to grant all EU citizens’ access to a safe and effective vaccine,” as it was based on more evidence.

Dr June Raine, chief executive of the UK’s MHRA, defended the rapid rollout yesterday, saying “no corners were cut” in its approval of the Pfizer vaccine.

“The way in which the MHRA has worked is equivalent to all international standards,” she added.

It comes after European regulators on Tuesday pushed back formal safety assessments of the Pfizer/Biontech and Moderna vaccines, meaning vaccinations will not take place on the continent until next year.

The EMA said it planned to decide on whether to approve the vaccine being developed by Pfizer and BioNTech by 29 December, meaning distribution will not start until 2021.

It also said it does not plan on making a ruling on the Moderna vaccine until 12 January. 

Meanwhile, America’s FDA does not expect to make a decision on vaccine approvals until mid-December.

Read more

Ryanair warns of ‘passport queue chaos’ with new EU border system

Elon Musk and Ryanair CEO Michael O’Leary face off amid acquisition rumors in a business meeting setting

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • Boris Johnson
  • Coronavirus
  • Vaccine

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Ryanair warns of ‘passport queue chaos’ with new EU border system

    Aviation
    Elon Musk and Ryanair CEO Michael O’Leary face off amid acquisition rumors in a business meeting setting
  • Barclays, HSBC, Lloyds, and NatWest among the first banks in the world to adopt new Swift framework for enhanced international consumer payments

    Business Wire
  • European Commissioner vows to probe Fifa sell-off amid furious backlash

    Sport Business
    Gianni Infantino takes a selfie with Donald Trump, Claudia Sheinbaum, and a man in a suit.
  • Uefa to boycott World Cup over Infantino’s Fifa sell-off following unanimous vote

    Sport Business
    Aleksander Čeferin, UEFA President, and Gianni Infantino, FIFA President, observing from a stadium box.
  • Can a team of retail veterans solve Argos’ catalogue of woes?

    Retail
    Argos storefront showcasing the latest product displays and promotional banners in a bustling city center location
  • Burnham bounce: PM gets popularity boost – at Farage’s expense

    Politics
    Andy Burnham laughing outdoors in a candid moment, May 2026, capturing a lighthearted political event atmosphere.
  • Strategic Partnership Between Record Asset Management and Admicasa

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook